MedTrace Logo

Blue Laser Imaging (BLI) for Detection of Secondary Head and Neck Cancer

NCT04566367 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2023-07-13

No results posted yet for this study

Summary

This study wants to focus on Carcinoma detection rates with blue laser imaging (BLI) for participants with head-neck cancer who need a percutaneous endoscopic gastrostomy (PEG). BLI is a new imaging technique that can easily be used within a standard gastroscopy.

Conditions

  • Head Neck Cancer
  • Esophageal Cancer
  • Gastrostomy

Interventions

DIAGNOSTIC_TEST

blue laser imaging

The intervention is the push on demand activation of blue laser imaging technique during gastroscopy.

Sponsors & Collaborators

  • Georg Dultz

    lead OTHER

Principal Investigators

  • Mireen Friedrich-Rust, Professor · Goethe University

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-22
Primary Completion
2023-02-02
Completion
2024-08-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04566367 on ClinicalTrials.gov